All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:
  1. Children in a playground

    Cost-effectiveness analysis of HPV vaccination of boys in Belgium

    KCE Reports 308 (2019) The vaccine for the human papilloma virus (HPV) which causes cervical cancer was introduced about ten years ago in Belgium, but only girls benefit from it. However, it is now established that this same virus is also involved in other cancers, including throat cancer. The recommendations have thus been reviewed and here, as in most western countries, it is now recommended to vaccinate boys too.

    https://kce.fgov.be/en/cost-effectiveness-analysis-of-hpv-vaccination-of-boys-in-belgium

  2. Use of pneumococcal vaccines in the elderly: an economic evaluation

    KCE Reports 274 (2016) Supplementary material pdf fileR274_Supplementary-file_Univariate-sensitivity-analyses (13.95 MB) pdf fileR274_Supplementary-file_Sensitivity-analyses_PPV23-price (1.1 MB) pdf fileR274_Supplementary-file_Multivariate-sensitivity-analyses_Net-benefit-Box-plots (1.16 MB) pdf fileR274_Supplementary-file_Multivariate-sensitivity-analyses_CEAFs-and-CE-planes (58.74 MB) The results are also available in a searchable spreadsheet-database format for all scenario and sensitivity analyses.

    https://kce.fgov.be/en/use-of-pneumococcal-vaccines-in-the-elderly-an-economic-evaluation

  3. Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening

    KCE Reports 238 (2015)

    https://kce.fgov.be/en/cervical-cancer-screening-program-and-human-papillomavirus-hpv-testing-part-ii-update-on-hpv-primary

  4. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effectiveness-study

  5. Seasonal influenza vaccination: prioritizing children or other target groups? - Part II

    KCE Reports 204 (2013)

    https://kce.fgov.be/en/seasonal-influenza-vaccination-prioritizing-children-or-other-target-groups-part-ii

  6. [Vaccine safety surveillance in Belgium : place and limits of a background rate approach]

    KCE Reports 188 (2012)

    https://kce.fgov.be/en/vaccine-safety-surveillance-in-belgium-place-and-limits-of-a-background-rate-approach

  7. Seasonal influenza vaccination: priority target groups – Part I

    KCE Reports 162 (2011)

    https://kce.fgov.be/en/seasonal-influenza-vaccination-priority-target-groups-%E2%80%93-part-i

  8. Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood

    KCE Reports 155 (2011)

    https://kce.fgov.be/en/cost-effectiveness-of-10-and-13-valent-pneumococcal-conjugate-vaccines-in-childhood

  9. Cost-effectiveness analysis of rotavirus vaccination of Belgian infants

    KCE Reports 54 (2007)

    https://kce.fgov.be/en/cost-effectiveness-analysis-of-rotavirus-vaccination-of-belgian-infants